Martini Wenjun Z, Dubick Michael A
From the US Army Institute of Surgical Research, Fort Sam Houston, San Antonio, Texas.
J Trauma Acute Care Surg. 2015 Oct;79(4):540-7; discussion 547-8. doi: 10.1097/TA.0000000000000819.
Fibrinogen plays a central role in coagulation and falls to critical levels early after trauma. Administration of fibrinogen concentrate (FC) to improve hemostasis after severe bleeding seems beneficial, but it is unclear whether its use introduces excessive fibrinogen with a potential risk of thrombosis. This study investigated changes of endogenous fibrinogen metabolism from FC administration following traumatic hemorrhage in pigs.
Anesthetized, instrumented pigs were randomized into lactated Ringer's (LR) solution only and LR plus FC groups (n = 7 each). Femur fracture of each pig's left leg was followed by hemorrhage of 60% total blood volume and resuscitation with LR (3× bled volume, LR group) or LR plus FC at 250 mg/kg (LR-FC group). Afterward, a constant infusion of stable isotopes 1-C-phenylalanine (phe, 6 hours) and d5-phe (3 hours) was performed with hourly blood sampling and subsequent gas chromatography-mass spectrometry analysis to quantify fibrinogen synthesis and breakdown rates, respectively. Blood gas and coagulation indices (thromboelastography) were measured on intermittent blood samples, and hemodynamics was continuously monitored. Animals were euthanized after the 6-hour isotope period.
Mean arterial pressure decreased by 50% after hemorrhage but improved after LR resuscitation in both groups. Hemorrhage and LR resuscitation reduced total protein, hematocrit, fibrinogen, and platelets to 50% of baseline values. Moreover, hemorrhage and resuscitation decreased fibrinogen concentration (207 ± 6 vs. 132 ± 7 mg/dL) and clot strength (72 ± 2 vs. 63 ± 2 mm) in both groups (p < 0.05). FC administration restored plasma fibrinogen concentrations and clot strength within 15 minutes, while no changes occurred in the LR group. Fibrinogen synthesis rates in the LR-FC group (1.3 ± 0.2 mg/kg/h) decreased versus the LR group (3.1 ± 0.5; p < 0.05), whereas fibrinogen breakdown rates were similar.
Our data suggest an effective feedback mechanism that regulates host fibrinogen availability and thereby suggests that acute thrombosis from FC administration is an unlikely risk.
纤维蛋白原在凝血过程中起核心作用,且在创伤后早期会降至临界水平。给予纤维蛋白原浓缩物(FC)以改善严重出血后的止血效果似乎有益,但尚不清楚其使用是否会引入过多纤维蛋白原并带来潜在的血栓形成风险。本研究调查了猪创伤性出血后给予FC引起的内源性纤维蛋白原代谢变化。
将麻醉并插管的猪随机分为仅给予乳酸林格氏液(LR)组和LR加FC组(每组n = 7)。每只猪左腿股骨骨折后,出血60%总血容量,然后用LR(3倍出血量,LR组)或250 mg/kg的LR加FC进行复苏(LR-FC组)。之后,持续输注稳定同位素1-C-苯丙氨酸(phe,6小时)和d5-phe(3小时),每小时采集血样,随后进行气相色谱-质谱分析,分别量化纤维蛋白原的合成和分解速率。对间歇性血样测量血气和凝血指标(血栓弹力图),并持续监测血流动力学。在同位素输注6小时后对动物实施安乐死。
出血后平均动脉压下降50%,但两组经LR复苏后均有所改善。出血和LR复苏使总蛋白、血细胞比容、纤维蛋白原和血小板降至基线值的50%。此外,出血和复苏使两组纤维蛋白原浓度(207±6 vs. 132±7 mg/dL)和凝血强度(72±2 vs. 63±2 mm)降低(p < 0.05)。给予FC后15分钟内血浆纤维蛋白原浓度和凝血强度恢复,而LR组无变化。LR-FC组纤维蛋白原合成速率(1.3±0.2 mg/kg/h)较LR组(3.1±0.5;p < 0.05)降低,而纤维蛋白原分解速率相似。
我们的数据提示存在一种有效的反馈机制来调节机体纤维蛋白原的可用性,从而提示给予FC导致急性血栓形成的风险不大。